Evidence map›Paper›PMID 38512930›Full record

ArticlePloS one2024

Anxiety disorders among youth with substance use and associated factors in Northwest Ethiopia: A community-based study.

Mamaru Melkam, Demeke Demilew, Tilahun Kassew, Biruk Fanta, Sewbesew Yitayih, Kassahun Alemu, Yassin Muhammed, Berhanie Getnet, Eden Abetu, Gebrekidan Ewnetu Tarekeg and 2 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mamaru MelkamDepartment of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.ORCID 0000-0001-7847-5709
Demeke DemilewDepartment of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Tilahun KassewDepartment of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Biruk FantaDepartment of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Sewbesew YitayihDepartment of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Kassahun AlemuDepartment of Biostatistics & Epidemiology, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Yassin MuhammedDepartment of Psychology, College of Social Science and Humanities, University of Gondar, Gondar, Ethiopia.
Berhanie GetnetDepartment of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Eden AbetuDepartment of Clinical Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Gebrekidan Ewnetu TarekegDepartment of Biostatistics & Epidemiology, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Mohammed OumerDepartment of Human Anatomy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Goshu NenkoDepartment of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnxiety disorder is an unpleasant emotional feeling with symptoms related to psychological and autonomic symptoms such as headache, perspiration, palpitations, dizziness, and stomach discomfort. The use of substances become a worldwide problem among youth which brings situation that leads to serious social and health-related problems. Anxiety disorders with substance use have a huge impact on their high prevalence, therapeutic issues, and poor prognosis on clinical effects. Although the prevalence of anxiety disorders is significant among young people who use substances, limited studies were conducted. Therefore, this study revealed the burden of anxiety disorders among youth with substance use and associated factors in Ethiopia.

methodA community-based multi-stage with a simple random sampling technique was conducted. A total of 372 substance users study participants were recruited for this study. Alcohol, Smoking, and Substance Involvement Screening Tests, Depression Anxiety Stress Scales, and other tools were used to assess anxiety disorders with substance use and associated factors. Data were entered into Epi-data version 4.6, and exported to SPSS version 20 for further analysis. Bi-variables logistic regression analysis was employed to identify variables with a p-value of < 0.2 and associated factors were determined in multi-variables logistic regression analysis with a p-value < 0.05 with AOR and CI.

resultsFrom a total of 372 respondents the overall prevalence of anxiety disorders with substance use was 48.1%. Male sex [AOR = 1.99; 95% CI: (1.01-3.93)], low educational status of the father [AOR = 6.38 95%CI: (1.50-7.08)], and the presence of stress [AOR = 2.48; 95% CI: 2.48(2.43-4.40)] were significantly associated factors with anxiety disorders with substances use. CONCLUSIONS AND RECOMMENDATIONS: The prevalence of anxiety disorders with substance use was 48.1% therefore; it is recommended that the zonal administration give collaborative work with the health bureau and facilitate awareness creation about the impact of substance abuse. Clinicians are recommended to mitigate anxiety disorders with substance use to get a good prognosis for clients with controlling their stress.

Indexed as

Substance-Related DisordersAdolescentAnxietyAnxiety DisordersCross-Sectional StudiesEthiopiaHumansMalePrevalenceSmoking

Identifiers

PMID38512930
PMCPMC10956842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.